Article Details

AstraZeneca to acquire CinCor to boost its heart and kidney business - Silicon Republic

Retrieved on: 2023-01-09 16:57:54

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to acquire CinCor to boost its heart and kidney business - Silicon Republic. View article details on hiswai:

Excerpt

AstraZeneca has entered an agreement to acquire CinCor in a deal worth up to $1.8bn, in order to expand its pipeline of cardiorenal drugs.

Article found on: www.siliconrepublic.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up